We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$4.49B
AUM Growth
+$113M
Cap. Flow
+$75.7M
Cap. Flow %
1.69%
Top 10 Hldgs %
35.01%
Holding
643
New
28
Increased
86
Reduced
146
Closed
38

Top Buys

Rank Stock Value
1
PAYC icon
Paycom
PAYC
+$21.7M
2
META icon
Meta Platforms (Facebook)
META
+$17.5M
3
AMT icon
American Tower
AMT
+$10.6M
4
DHR icon
Danaher
DHR
+$8.77M
5
SBUX icon
Starbucks
SBUX
+$8.06M

Sector Composition

Rank Sector Weight
1 Technology 23.07%
2 Healthcare 17.68%
3 Consumer Staples 12.48%
4 Consumer Discretionary 10%
5 Industrials 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRBT
426
DELISTED
iRobot
IRBT
$35K ﹤0.01%
600
MUR icon
427
Murphy Oil
MUR
$5.06B
$35K ﹤0.01%
1,125
TM icon
428
Toyota
TM
$223B
$34K ﹤0.01%
290
ABB
429
DELISTED
ABB Ltd
ABB
$34K ﹤0.01%
1,600
PHX
430
DELISTED
PHX Minerals
PHX
$33K ﹤0.01%
1,405
XYL icon
431
Xylem
XYL
$28.5B
$33K ﹤0.01%
661
AME icon
432
Ametek
AME
$59.3B
$32K ﹤0.01%
655
LBTYA icon
433
Liberty Global Class A
LBTYA
$3.55B
$32K ﹤0.01%
1,031
LH icon
434
Labcorp
LH
$26.2B
$32K ﹤0.01%
291
PRU icon
435
Prudential Financial
PRU
$42.3B
$32K ﹤0.01%
303
+144
+91% +$13.7K
RIG icon
436
Transocean
RIG
$6.37B
$32K ﹤0.01%
2,204
-6,855
-76% -$81.2K
NEM icon
437
Newmont
NEM
$124B
$31K ﹤0.01%
900
TEVA icon
438
Teva Pharmaceuticals
TEVA
$42.8B
$31K ﹤0.01%
850
QCP
439
DELISTED
Quality Care Properties, Inc.
QCP
$31K ﹤0.01%
+2,027
New +$30.4K
SHPG
440
DELISTED
Shire pic
SHPG
$31K ﹤0.01%
181
KMI icon
441
Kinder Morgan
KMI
$70.7B
$30K ﹤0.01%
1,430
-2,233
-61% -$47.2K
KR icon
442
Kroger
KR
$34.3B
$30K ﹤0.01%
883
-2,280
-72% -$74.3K
MNTA
443
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$30K ﹤0.01%
2,000
WOLF icon
444
Wolfspeed
WOLF
$1.65B
$29K ﹤0.01%
1,095
BX icon
445
Blackstone
BX
$110B
$28K ﹤0.01%
1,025
DISCB
446
DELISTED
Discovery, Inc. Series B Common Stock
DISCB
$28K ﹤0.01%
1,000
AZN icon
447
AstraZeneca
AZN
$246B
$27K ﹤0.01%
499
CAC icon
448
Camden National
CAC
$990M
$27K ﹤0.01%
600
IBB icon
449
iShares Biotechnology ETF
IBB
$9.86B
$27K ﹤0.01%
300
-240
-44% -$21.8K
AIVL icon
450
WisdomTree US AI Enhanced Value Fund
AIVL
$436M
$26K ﹤0.01%
327

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Loring Wolcott & Coolidge Fiduciary Advisors held 643 positions worth $4.49B, up 2.6% from $4.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2016 filing shows 28 new, 86 increased, 146 reduced and 38 closed positions. Its largest new stake was Adient: 27,453 shares worth $1.61M. The largest sale was Novo Nordisk, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2016 buy was Adient: 27,453 shares worth $1.61M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Paycom in Q4 2016, an estimated $21.7M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2016 reduction was Novo Nordisk, cutting an estimated $10.4M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Invesco Water Resources ETF in Q4 2016, selling an estimated $148K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 35% of its $4.49B portfolio in Q4 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 28 new positions and closed 38 in Q4 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 2.6% quarter-over-quarter to $4.49B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2016, filed 2 Feb 2017.